🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Paula Dakin

Regeneron (United States)

ORCID: 0000-0002-8925-0414

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial”.

Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(25)00044-x

N/A

0.829DataRank · unranked

24 citations

Nicola A. Hanania, Surya P. Bhatt, Mona Bafadhel, Klaus F. Rabe, Claus Vogelmeier +11 more

Dupilumab Improves Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUS

CHEST Journal(2025)10.1016/j.chest.2025.01.029

N/A

0.421DataRank · unranked

13 citations

Klaus F. Rabe, Nicola A. Hanania, Claus Vogelmeier, Mona Bafadhel, Stephanie A. Christenson +11 more

Casirivimab and Imdevimab Treatment in Seropositive, Hospitalized COVID-19 Patients With Non-neutralizing or Borderline Neutralizing Antibodies

medRxiv(2022)10.1101/2022.06.14.22276389

N/A

0DataRank · unranked

0 citations

Selin Somersan-Karakaya, Shane McCarthy, Eleftherios Mylonakis, Shazia Ali, Jingning Mei +9 more